Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Bio-Technology General's OxSODrol tested for safety and efficacy

Jan. 13, 1997

French investigators announce success of gene therapy for CF

Jan. 13, 1997

Dual TNF/PDE IV inhibitors described by Chiroscience

Jan. 13, 1997

RPR seeks FDA approval for Nasacort-HFA

Jan. 10, 1997

SciClone cystic fibrosis drug cleared for clinical testing

Jan. 10, 1997

Generic terfenadine approved for U.S. marketing

Jan. 10, 1997

Merck Frosst discloses leukotriene biosynthesis inhibitors

Jan. 10, 1997

New IL-4 antagonist from Hoechst

Jan. 10, 1997

ICOS-Suntory j.v. to develop rPAF-AH

Jan. 9, 1997

Nasalcrom cleared by FDA as OTC

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026